Aclarion announces $3M public offering

Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26.

Advertisement

The company listed 5,175,000 units at  58 cents each, according to a news release.

In the last year, Aclarion has leveraged the expertise of spine surgeons including Roger Härtl, MD, to develop its Nociscan platform for diagnosing lower back pain. Alphatec also partnered with the company to include Nociscan with its AlphaInformatiX spine platform.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.